Aye!!! pslabowski, ankur, stoli and anyone else who do these types of spreadsheets. Remember our talk about the need for Kaul to keep his cards close to his chest? He can't be this predictable, can he? :O
Same here. I appreciate pslabowski sharing his spreadsheet and wisdom. I'm also looking at trends and market direction, and the fun banter.
I've been accumulating quite a large sum after time-averaging buying for over 15 years and I'm about 5 years from meeting early retirement age cutoff at my company. My systematic investment plan is 1/3 in biotech and health care, 1/3 in tech/wireless and 1/3 everything else (mid-cap and small-cap growth) and for the past 2-3 years that biotech has been thriving, my portfolio has been gaining disproportionately but in a good way. I've started to track biotech more closely just because it takes up so much of my portfolio, 45% a few days ago..,. On top of that, I couldn't resist buying the dip. S**t, I need to find a cure for this addiction.
Oh cr*p, that's not what I wanna hear. IBB is currently down 1.09%... BIIB, GILD, CELG, REGN are currently tanking hard so both FBIOX and IBB are taking it on the chin.
This "bull run" that talking heads are yapping on CNBC is beginning to annoy me. Maybe I'll do one last dip buying and then stop looking at this fund for the next 6 months.
Quit quibbling. Someone, please tell me why this biotech sector is so unloved today!!!! I can understand profit taking but not while the rest of the market isn't moving much.
FWIW, I look at the real-time IBB as the benchmark for biotech, and then the percentages of the 10 holdings which weigh about 54-55% of FBIOX total assets. If I can access FBIOX's top 25 or 30 and get a feel of ~75% of total assets, I'm good.
Something weird is going on with the Yahoo servers. #$%$!!!! One minute they're showing deep red (which I know is the correct version) then they switch to green and 0.00%...
It wasn't that. It was the recall involving GILD. .. overblown reaction if you ask me
Aye!!! That was an ugly close. Thanks for posting, P. Since I decided to buy more, I'll take it.
I think GILD is the likely culprit because (unlike CELG, REGN, ICPT...) GILD rarely moves that much in a day unless there' s a reason. Found this tidbit posted on GILD board. FWIW. ..
(Forgot the poster's name)
"Down today apparently due to recall of 39000 vials of Atriplia HIV drug. Small amount of rubber particles found by Gilead and they notified FDA and did voluntary recall. Lot was manufactured in China but several other suppliers are available. It should recover from this quickly."
It might be good buying op... Was looking for GILD news since the stock is pulling the sector down hard. And people on GILD board were wondering the same thing and blaming on the biotech sector pulling down GILD. Regardless, SOMETHING is pulling down our sector while the rest of themarket is recovering. The health care sector is also down and you can blame it on GILD also. I don't think the talks in Washington about the 2-year delay of Obamacare has anything to do with this but who knows.
Well, I'm buying more since I recently got out of telecom and global growth funds. I'm looking for a bounce tomorrow and rest of the month. Long term!
That's what I'd like to know too. :(
An article just appeared on Barron's today.
March 6, 2014, 2:17 P.M. ET
Biotech: What the Heck Happened?
By Brendan Conway
Attributing a day’s decline in stocks to “loss of momentum” is a bit like the undertaker who, standing over the corpse dumbfoundedly, says, “He died from loss of breath.”
And yet, it looks as though this is exactly the explanation for high-flying biotechnology stocks’ Thursday selloff. There’s no obvious news catalyst, and yet the charts have weakened steadily as the session wears on. Gilead Sciences (GILD) is down more than 4%. Sought-after ETFs iShares Nasdaq Biotechnology ETF (IBB) and SPDR S&P Biotech ETF (XBI) are down 2%-3%...
Thanks P, I found the cash portion now. December was a great month for the bull. I didn't dare buy but in hindsight, I'm glad Kaul did and he did A LOT because the biotech advanced some more in Jan and Feb despite the steep market correction.
Interesting! I see AGIO got listed twice in the updated report. What does it mean? I hope it's good.
Agios Pharmaceuticals, Inc. $2,207,438 ---- 0.023%
Agios Pharmaceuticals, Inc. $1,807,408 ---- 0.019%
Awesome! FBIOX holds these 3 stocks, albeit very tiny volume of AGIO:
Agios Pharmaceuticals, Inc. (AGIO) 41.30 Up 9.66 (+30.53%)
Karyopharm Therapeutics, Inc. (KPTI) 46.61 Up 8.62 (+22.69%)
Sangamo Biosciences Inc. (SGMO) 23.78 Up 4.17 (+21.26%)
From FBIOX holdings (01/31/14)
Sangamo Biosciences, Inc. ------- $74,294,320 --------- 0.771%
Karyopharm Therapeutics, Inc. ----- $71,763,859 ------ 0.744%
Agios Pharmaceuticals, Inc. -------- $1,807,408 ----------- 0.019%
That's helpful and thank you for being so thorough. Are you able to get the cash portion amount from the January update? I can't find it anywhere and I also wish we can tell the days in the month that he bought and sold something instead of just the end of the month. I guess Kaul (or fund managers in general) didn't expect investors to be so in tune with his investment ideas. LOL
Looks like a red day for the biotech today. Do you see any notable jumps?
Don't tell cscrutter that Kaul hasn't sold any shares of AEGR during January. :( The number 2,173,495 stays the same in the latest update. Hopefully, he's sold some in February...?
Biggest gains were seen by:
ARWR: $7.95M (Note: This was one of the NEW stocks added in January)
Stocks with FBIOX holdings over $1M showing the largest gains in percentage were:
ARWR: 26.63 +5.49 (+25.9%)
AVNR: 4.93 +0.63 (+14.6%)
@pslabowski - Thanks for pointing us this gem ARWR above. Morningstar updated their portfolio dates to 01/31/14 finally. The "first bought" dates are all listed at the end of the months. Do you suppose fund managers purchase shares throughout the month, or only during end of the month? ARWR went from $10/shr to $15/shr during January.
Relypsa Inc. (RLYP) is another new buy. Have you mentioned this one before? It's up 61.2% YTD. Great pick, Kaul!
Hello, welcome aboard, Ron! I hope you like wearing short skirts because we're recruiting for our cheerleading quad. :)
It seems we have a steady stream of people coming through but I dunno if they've sold or not.